Skip to main content
Clinical Trials/DRKS00025765
DRKS00025765Recruiting未知

MEGA Trial - Minimally invasivE versus open Gastrectomy.A multicenter randomized controlled trial. - MEGA

niversitätsklinikum Heidelberg0 sites160 target enrollmentStarted: December 22, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
160

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 84 Years (—)
Sex
All

Inclusion Criteria

  • Planned total gastrectomy after first diagnosis of gastric cancer
  • - Ability of patient to understand character and individual consequences of the clinical trial
  • - Written informed consent

Exclusion Criteria

  • - ECOG performance status > 2
  • - Planned extended gastrectomy or less than total gastrectomy (e.g. adenocarcinoma of esophagogastric junction (AEG) I and AEG II, distal gastric tumors of intestinal subtype)
  • - Previous gastric surgery or extensive adhesions seriously complicating MIG
  • - Other active oncologic disease or history of cancer limiting prognosis in comparison to the gastric cancer
  • - Emergency setting
  • - Language problems rendering patient unable to fill out patient reported outcome questionnaires
  • - Participation in another intervention-trial with interference of intervention and/or outcome of this trial
  • - Pregnancy
  • Exclusion criteria previously or during staging
  • laparoscopy:

Investigators

Sponsor
niversitätsklinikum Heidelberg

Similar Trials

MEGA Trial - Minimally invasivE versus... | Clinical Trial